Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Combined hormonal contraception and the risk of venous thromboembolism: a guideline. Fertil Steril 2017 Jan;107(1):43-51

Date

11/05/2016

Pubmed ID

27793376

DOI

10.1016/j.fertnstert.2016.09.027

Scopus ID

2-s2.0-85006010754 (requires institutional sign-in at Scopus site)   130 Citations

Abstract

While venous thromboembolism (VTE) is rare in young women of reproductive age, combined oral contraceptives increase the risk of VTE. In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation.

Author List

Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine

Author

Jay I. Sandlow MD Chair, Professor in the Urologic Surgery department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Age Factors
Blood Coagulation
Contraceptives, Oral, Combined
Contraceptives, Oral, Hormonal
Dose-Response Relationship, Drug
Female
Humans
Obesity
Patient Selection
Pulmonary Embolism
Risk Assessment
Risk Factors
Smoking
Thrombophilia
Venous Thromboembolism
Venous Thrombosis